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CD8 T Cells and IFN-g Emerge as
Critical Players for Psoriasis in a
Novel Model of Mouse Psoriasiform
Skin Inflammation
Paola Di Meglio1 and Joa˜o H. Duarte1
A pathogenic crosstalk between epithelial and immune cells underpins the
aberrant immune and epidermal responses seen in psoriasis. Data from a novel
mouse model of psoriasiform skin inflammation not only highlight the importance
of the interplay between keratinocytes, targets of genetic manipulation, and
T cells as the major effector cells, but also reveal a critical role for CD8 T cells and
IFN-g in disease initiation.
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The complex etiopathogenesis of psoriasis
results from the interaction of genetic and
environmental factors, leading to dysregu-
lated immune responses that manifest in
the skin as prominent epidermal hyper-
plasia and an inflammatory infiltrate.
Although a critical role for T cells is undis-
puted, it has become increasingly evident
that a pathogenic crosstalk between cells
of the innate and adaptive immune sys-
tems, which also include keratinocytes
(KCs) as ancillary innate immune cells,
underpins the aberrant immune and epi-
dermal responses (Di Meglio et al., 2011).
Psoriasis susceptibility genes identified
thus far fall broadly into three cate-
gories—tissue-specific, immunologically
innate, and immunologically adaptive
(Capon et al., 2012)—further pointing
toward critical contributions from both
epithelial cells and immune cells in
disease initiation.
See related article on pg 955
Contributions of mouse models of
psoriasiform skin inflammation to disease
understanding
Mouse models of psoriasiform skin
inflammation have been used since
the early 1990s to elucidate the
mechanisms that underlie the human
disease (Gudjonsson et al., 2007). For
instance, the description of a mouse
strain with an intragenic deletion on
the sharpin gene affecting homeostatic
NF-kB signaling was found to develop
skin inflammation spontaneously with
some similarities to psoriasis, such as
epidermal thickening and intradermal
microabscesses. Notably, however, it
lacked other important pathological
features of human psoriatic lesions,
such as epidermal T-cell infiltrates
(HogenEsch et al., 1993). The extent to
which different mouse models can
recapitulate the entire scope of
pathological features of psoriasis is a
common discussion point—how faithful
can a mouse model of psoriasis be,
when mouse and human skin have
such marked differences at structural
and cellular levels? In addition to the
genetic differences between the two
species, the environmental challenges
for mice and humans are quite different,
yet still very relevant for disease
initiation. By this time, the quest for a
system that could satisfactorily model
psoriasis was just beginning, and in
the past decade a range of transge-
nic (Gudjonsson et al., 2007) and
pharmacological (van der Fits et al.,
2009) models have been descri-
bed, some of which recapitulate the
human disease almost completely. As
such, genetic manipulation of the signal
transducer and activator of transcription
3 (STAT3), NF-kB, and AP-1 pathways
in KC has yielded a number of different
models with different specificities, but
all reproducing the epidermal structural
changes and lymphocytic infiltrates
common to psoriasis and pointing to
the importance of the epithelial cellular
compartment in establishing psoriasi-
form skin inflammation. On the other
hand, a different approach to modeling
psoriasis using a xenotransplantation
model has emphasized the importance
of the lymphocytic compartment
(Boyman et al., 2004; Conrad et al.,
2007). By using human psoriatic skin
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engrafted in immune-deficient mice, it
became clear that CD4 and CD8 T cells
constitute important effectors in the
disease through their production of
disease-relevant cytokines.
Psoriasis immunopathogenesis
Analogous to other immune-mediated
disease, psoriasis has long been consid-
ered a T helper (Th)-1-type and IFN-g-
driven disease. Early studies found
increased levels of IFN-g mRNA in
lesional psoriatic skin and showed that
the majority of epidermal T cells from
both skin lesions and the peripheral
blood of psoriatic patients produced
IFN-g (Austin et al., 1999). These initial
observations were substantiated further
by the identification of a strong IFN-g
genomic signature in lesional psoriatic
skin (Bowcock et al., 2001). However,
the discovery of IL-23 and the
identification of Th17 cells as major
players in autoimmunity set the scene
for a reevaluation of the immunopatho-
genesis of psoriasis, with the focus shifted
to a pivotal role for the IL-23/IL-17 axis
(Di Cesare et al., 2009). Analysis of the
lymphocytic infiltrates in psoriatic skin
showed that both ab- (Lowes et al.,
2008) and dermal gd-T cells (Cai et al.,
2011) are responsible for the production
of IL-17 found in the skin, and a popula-
tion of T cells coproducing IL-17A and
IFN-g was identified in lesional skin
(Lowes et al., 2008).
Although the recent focus of psoriasis
research has been on Th cells, cytotoxic
CD8 T (Tc)-cell involvement in disease
pathogenesis has also been suspected.
Despite not forming a large proportion
of lymphocytes in the skin, CD8 T cells
have been shown to be increased in the
epidermis of lesional psoriatic skin
(Hammar et al., 1984), where they are
ideally located to respond to potential
KC autoantigens on HLA class I
molecules, with the HLA-Cw0602*
allele being the strongest genetic
determinant for psoriasis (Capon et al.,
2012). CD8 T cells participate not only
in the production of IL-17A but also in
that of tumor necrosis factor (TNF) and
IFN-g (Austin et al., 1999; Kryczek et al.,
2008; Ortega et al., 2009). Of interest,
the simultaneous expression of IFN-g
and IL-17A has been associated with
the plastic properties of CD4 T cells
(Hirota et al., 2011), where a switch
in the transcriptional effector program
has been found to be responsible for
pathological changes in other auto-
immune diseases.
Ras overexpression in suprabasal KCs
in mice results in a psoriasiform skin
phenotype driven by CD8 T cells and IFN-c
In this issue of JID, Gunderson et al.
(2013) show development of psoriasi-
form skin inflammation, following doxy-
cycline-dependent overexpression of
activated H-Ras in suprabasal KCs.
H-Ras is a member of the Ras
superfamily of small GTPases, which
was identified as an oncogene 430
years ago and is involved in a wide
range of biological processes such as
cell cycle progression, growth, migra-
tion, cytoskeletal changes, apoptosis,
and senescence (Fernandez-Medarde
and Santos, 2011). The skin phenotype
in Ras-overexpressing mice strongly
resembles human psoriasis, with
basal KC hyperproliferation, acanthosis,
hyperkeratosis, intraepidermal neutro-
phil microabscesses, and T-cell infilt-
ration. Affected skin shows the typical
psoriasis signature, with increased
mRNA levels of psoriasis-relevant
transcripts, including proinflammatory
cytokines (IL-23p19, TNF, G-CSF, and
GM-CSF), chemokines (CXCL1, CCL2,
and MIP-2), and antimicrobial peptides
(DEFB-2, CAMP, S100A7A, S100A8,
and S100A9). As such, most of the
cellular and molecular players and
structural changes found in psoriatic
skin were reproduced, pinpointing the
relevance of this mouse as a suitable
model of the disease.
This psoriasiform skin inflammation
model required T cells for disease devel-
opment because Ras overexpression on
a Rag1 / background abrogated
neutrophil recruitment and reduced skin
acanthosis. Among infiltrating T cells,
Th17 and Tc1/17 double producing
IFN-g and IL-17A were increased sig-
nificantly in the skin. However, only
CD8 T- but not CD4 T-cell depletion
reduced epidermal hyperproliferation,
as well as skin and blood neutrophilia.
Conversely, CD8 T-cell reconstitution
of Rag1 / mice restored the skin
inflammation. Finally, the authors iden-
tified IFN-g as a critical driving mediator
in this model, as IFN-g neutralization,
but not IL-17A neutralization, bloc-
ked CD8-mediated skin inflammation
and KC hyperproliferation (Gunderson
et al., 2013). These findings by
Gunderson et al. (2013) lend further
support to the importance of the inter-
play between the epithelial and immune
compartment of the skin, put CD8
T cells under the spotlight, and call for
a reevaluation of the role of IFN-g in
disease pathogenesis (Figure 1).
Although the genetic manipulation
triggering this murine model of psoriasi-
form skin inflammation takes place in
epidermal KCs, the full disease deve-
loped only in the presence of CD8
T cells. These findings support the view
that the disease develops from an inter-
action between ancillary KC and effec-
tor immune cells. KCs initiate this
pathogenic crosstalk by recruiting dis-
ease-driving CD8 T cells, although how
this happens remains to be established, as
the nature of the interaction between KCs
and CD8 T cells remains unknown. It has
been reported that Ras activation is higher
in psoriatic lesions (Lin et al., 1999),
providing further support to the validity
of the model. However, how would Ras
activation result in increased recruitment
and activation of CD8 T cells? It could be
Clinical Implications
 The pathogenic crosstalk between the epithelial and immune compart-
ments in the skin underpins the aberrant immune and epidermal
responses seen in Ras-overexpressing mice and psoriasis.
 CD8 T cells are capable of orchestrating psoriasiform skin inflammation,
and their contributions to the pathogenesis of psoriasis should be the
focus of further investigation.
 IFN-g is a critical mediator in psoriasiform skin inflammation, calling for a
reevaluation of its usefulness as a therapeutic target in treating psoriasis.
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hypothesized that the increased prolifera-
tion status of the Ras-transformed KCs
results in an alteration in their differentia-
tion program, with an impact on their
activation state. One possibility is that Ras-
overexpressing KCs produce increased
amounts of chemotactic CXCL16, which
has been recently shown to mediate
homing of CD8 T cells into human skin
through interaction with CXCR6, preferen-
tially expressed on CD8 T cells (Gunther
et al., 2012).
In particular, the mouse model of
psoriasiform inflammation developed
by Gunderson et al. (2013) sheds new
light on the contributions of CD8 T cells
in psoriasis.
Although they represent only 5% of the
skin-infiltrating lymphocytes in Ras-over-
expressing mice, CD8 T cells were capable
of initiating psoriasiform skin inflamma-
tion. They produce both IFN-g and IL-17A,
favor neutrophil recruitment and micro-
abscess formation, enhance KC prolifera-
tion, and aid in CD4 T-cell activation. In
particular, CD8 T cells favor CD4 T-cell
infiltration into the skin and also affect
the frequency of IL-17-producing gd and
Th17 cells, suggesting that a previously
unappreciated proinflammatory axis exists
between CD8 and CD4/gd-T cells.
As occurs in psoriatic lesions, CD8
T cells accumulated preferentially in the
epidermis of the Ras-overexpressing
mice, where they were strategically
located to interact with KCs. Conrad
et al. (2007) showed that expansion of
epidermal rather than dermal T cells
correlated with disease progression in
the AGR129 mice xenotransplantation
model of psoriasis. Moreover, neutra-
lization of very-late antigen-1/a1b1
integrin, expressed on epidermal T
cells, blocked epidermal infiltration
and prevented psoriasis development
(Conrad et al., 2007). It is possible that
CD8 T-cell localization is a key deter-
minant of the tissue-specific immune
response and is critical for their patho-
genicity in psoriasis. However, the pre-
sence of cytotoxic CD8 T-cell-expres-
sing perforin and granzyme B still
remains to be reconciled with a
disease characterized by cell hyper-
proliferation and reduced apoptosis.
One of the most unexpected findings
shown in the Ras-overexpressing mouse
model is the striking importance of
IFN-g over that of IL-17A in driving
disease pathogenesis. While IFN-g drives
disease development, IL-17A seems to
have a minor role and perhaps intervenes
only in the subsequent amplification of
the skin inflammation. Whether this is an
intrinsic feature of the model remains to
be tested; however, accumulating evi-
dence in the literature encourages a reas-
sessment of the contribution of IFN-g to
psoriasis pathogenesis. Although IFN-g is
known to inhibit the production of IL-17
by T cells in vitro, recent studies suggest
that it can program dendritic cells to
produce IL-23 and IL-1, promoting IL-17
production by memory T cells (Kryczek
et al., 2008). Therefore, it is possible that
CD8 T-cell-derived IFN-g promoted the
increased frequency of IL-17-producing T
cells in the skin of Ras-overexpressing
mice through this mechanism. Moreover,
Johnson-Huang et al. (2012) have recently
shown that a single intradermal injection
of IFN-g in nonlesional skin of psoriasis
patients is capable of inducing several
molecular and histological features char-
acteristic of psoriatic lesions (increased
expression of chemokines, S100 family
members, and adhesion molecule genes,
as well as influx of T cells and inflam-
matory dendritic cells), despite not cau-
sing visible changes in the skin (Johnson-
Huang et al., 2012).
Neutralization of IFN-g in RAS-over-
expressing mice markedly affected KC
proliferation (Gunderson et al., 2013).
Although IFN-g is known to inhibit pri-
mary KC growth in vitro, altered responses
to IFN-g have been shown in psoriatic KCs
(Baker et al., 1988). In this regard, it is also
worth mentioning that regular cutaneous
injections of IFN-g, administrated to
patients in an early attempt to use it as a
therapeutic for several immune-mediated
diseases (including psoriasis; Fierlbeck
et al., 1990), caused a ‘‘psoriasis-like’’
injection-site reaction, characterized by
induration, erythema, epithelial thicken-
ing, and accumulation of T cells and
monocytes in the dermis.
Although additional studies on the
role of IFN-g are required using other
model systems, it is nevertheless tempt-
ing to translate these findings into a
clinical scenario. Fentolizumab, an
anti-IFN-g mAb, has shown some effi-
cacy in Crohn’s disease (Reinisch et al.,
2010). However, no data are available
regarding IFN-g blocking in psoriatic
patients, although this approach had
been suggested over 9 years ago
(Skurkovich and Skurkovich, 2003).
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Figure 1. CD8 T cells mediate Ras-induced psoriasis-like skin inflammation through IFN-c.
Overexpression of activated Ras in suprabasal keratinocytes (KC) resulted in psoriasiform skin inflammation
with skin acanthosis, hyperkeratosis, and intraepidermal neutrophil (N) and T-cell infiltration, including
IL-17Aþ IFN-gþ CD8þ T cytotoxic (Tc1/17) cells. Ras-overexpressing KCs might recruit Tc1/17 cells
through the release of CXCL16 interacting with CXCR6 specifically expressed on CD8þ T cells, also
possibly bearing very-late antigen (VLA-1) expression, which favors epidermal localization. Proinflammatory
cytokines released by Tc1/17 cells, especially IFN-g, enhance KC activation and proliferation, promoting KC
production of neutrophil-attractant CXCL1 and S100 family members (S100A7, S100A8, and S100A9).
Moreover, IFN-g favors Th-17 and IL-17þ gd-T-cell infiltration into the skin, possibly by programming
dendritic cells to produce IL-17-driving cytokines IL-23 and IL-1 and chemoattracting CCL2 and MIP-2.
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The success of anti-TNF agents, as well
as the more recent outburst of highly
effective biologics targeting the IL-23/IL-
17 axis, should not overshadow the fact
that there is still a sizable number of
nonresponder patients who might
benefit by an alternative strategy.
The mouse model described by
Gunderson et al. (2013) uncovers
an important aspect of CD8 T-cell
pathogenicity in skin inflammation
mediated by IFN-g, while posing new
critical questions. Answering them will
enhance our understanding of the
pathological mechanisms underlying
psoriasis and could ultimately lead to
novel effective therapeutic strategies.
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Toll-Like Receptors Link Atopic March
to the Hygiene Hypothesis
Lajos Keme´ny1,2 and Korne´lia Szabo´1
In recent decades, the prevalence of atopic diseases has increased substantially
worldwide, but their molecular pathologies are now being elucidated. The report
by Haapakoski et al. in this issue suggests that the manner in which the immune
system encounters an allergen is key to the subsequent polarization of its
responses, and the presence of microbial ligands appears to be important in this
process. Data in this report provide further proof of the hygiene hypothesis that
combine it with known features of the atopic march.
Journal of Investigative Dermatology (2013) 133, 874–878. doi:10.1038/jid.2013.11
The hygiene hypothesis was first intro-
duced in 1989 by David P Strachan,
who proposed, based on epidemiological
studies, that changes in personal hygiene,
improvements in household amenities,
and declining family sizes had been
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